These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27721955)

  • 1. Findings of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy after 16 Years.
    Kim GH; Kim CM; Jang BH; Lee HH; Hong S; Eum SH; Jeon H; Moon D
    J Cardiovasc Ultrasound; 2016 Sep; 24(3):239-242. PubMed ID: 27721955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of different assesment methods of myocardial fibrosis in patients with hypertrophic cardiomyopathy.].
    Zaitsev VV; Gurshchenkov AV; Mitrofanova LB; Ryzhkov AV; Kazakova EE; Badaev KD; Gordeev ML; Moiseeva OM
    Kardiologiia; 2020 Jan; 60(3):44-50. PubMed ID: 32375615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of hypertrophic cardiomyopathy to dilated cardiomyopathy--a case reports and review of the literatures.
    Chang KH; Ha JW; Chung NS; Cho SY
    Yonsei Med J; 1998 Feb; 39(1):61-6. PubMed ID: 9529987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
    Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of apical hypertrophic cardiomyopathy of the left ventricle].
    Skopetckaya SA; Leonteva TV; Musurivskaya TV; Serebryannikova OS
    Kardiologiia; 2022 Feb; 62(2):42-46. PubMed ID: 35272607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.
    Frustaci A; De Luca A; Guida V; Biagini T; Mazza T; Gaudio C; Letizia C; Russo MA; Galea N; Chimenti C
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overlapping Phenotype: Left Ventricular non-Compaction and Hypertrophic Cardiomyopathy].
    Komissarova SM; Rineiska NM; Chakova NN; Niyazova SS
    Kardiologiia; 2020 Mar; 60(4):137-145. PubMed ID: 32394868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes.
    Nishimura T; Nagata S; Sakakibara H
    Jpn Circ J; 1988 May; 52(5):395-400. PubMed ID: 3411762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction.
    Sechtem U; Sommerhoff BA; Markiewicz W; White RD; Cheitlin MD; Higgins CB
    Am J Cardiol; 1987 Jan; 59(1):145-51. PubMed ID: 2949575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging.
    Mangold S; Kramer U; Franzen E; Erz G; Bretschneider C; Seeger A; Claussen CD; Niess AM; Burgstahler C
    Rofo; 2013 Dec; 185(12):1167-74. PubMed ID: 23897528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial Mass with an Echo-Free Center as an Echocardiographic Presentation of Hypertrophic Cardiomyopathy.
    Alizadeh-Sani Z; Hosseinsabet A
    J Tehran Heart Cent; 2021 Apr; 16(2):89-91. PubMed ID: 35082878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular dysfunction in hypertrophic cardiomyopathy evaluated by cardiac magnetic resonance and computed tomography.
    Moral S; Fernandez-Friera L; Sanz J
    Acta Cardiol; 2010 Jun; 65(3):367-9. PubMed ID: 20666282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].
    Alieva IN; Blagova OV; Gagarina NV; Nedostup AV; Kogan EA; Sedov VP; Kadochnikova VV; Donnikov AE; Zaidenov VA; Kupriyanova AG; Ternovoy SK
    Ter Arkh; 2017; 89(12):15-27. PubMed ID: 29411756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy.
    Bax JJ; Lamb H; Dibbets P; Pelikan H; Boersma E; Viergever EP; Germano G; Vliegen HW; de Roos A; Pauwels EK; Van der Wall EE
    Am J Cardiol; 2000 Dec; 86(12):1299-305. PubMed ID: 11113402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating a Structural Heart Disease Using a Non-structural Approach: Role of Cardiac Pacing in Hypertrophic Cardiomyopathy.
    Albano BB; Fadreguilan EC; Chua JM; Ho J; Medrano AB
    Cardiol Res; 2017 Feb; 8(1):20-25. PubMed ID: 28275421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A
    Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage.
    Fujiwara H; Onodera T; Tanaka M; Shirane H; Kato H; Yoshikawa J; Osakada G; Sasayama S; Kawai C
    Jpn Circ J; 1984 Nov; 48(11):1210-4. PubMed ID: 6542151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.